Plant-based Biologics Market - Global Industry Analysis, Size, Trends, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Plant-based Biologics Market - Global Industry Analysis, Size, Trends, Growth, Trends, and Forecast 2018 - 2028

Status : August, 2020 | Food and Beverages | PPT format

Report Digest

Global Plant-based Biologics Market: Overview

Demand for biologics that the world is witnessing right now is difficult to meet by mammalian cell culture production. A number of reasons stand behind this challenges. One, the availability is limited and two, the scalability is limited. In such a scenario, it is a major plus that plant-based alternatives are available which are quality substitutes to mammalian variants. Besides, advancement in glycoengineering, downstream processing and expression vectors is helping plant variants gain steam.

It is noteworthy here that plants can reduce the cost of a biologic and at the same time, these can be as effective in eukaryotic protein modification as animal cultures. And, thus as per a Transparency Market Research analysis, it will be the next major development in biotechnology, driving market on a growth curve charted by a robust CAGR (Compound Annual Growth Rate)

Global Plant-based Biologics Market: Notable Developments

The landscape of Global Plant-based Biologics Market is at the cusp of transformation, owing to notable developments that are contributing largely to shaping its future, including competitive landscape. A glimpse is provided below.

In 2017, Denka, a Japanese company, acquired Icon Genetics Inc, a plant biotech company based out of Germany. The acquisition was worth USD 85 million and it clearly improves the market share and penetration of Denka which can further solidify its position as it can now focus on vaccines and diagnostics reagents, in order to develop new biopharmaceuticals. This is inclusive of biosimilar and ‘biobetter’ antibodies.

The global plant-based biologics market is highly consolidated. And, prominent players in the global plant-based biologics market are PlantForm, IBio Inc., Mapp Biopharmaceutical, Inc., Pfizer Inc., Ventria Bioscience, Medicago Inc., Greenovation Biotech GmbH, Kentucky BioProcessing, PhycoBiologics Inc., Synthon, Fraunhofer IME, Healthgen, PlanetBiotechnology, and Icon Genetics GmbH among others.

Current focus for most companies to chart growth in the global plant-based biologics market is through improving product and focusing on research and development (R&D). Thus, it does not come as a surprise that R&D is a critical focal point. Additionally, to stay ahead of the curve, players opt for mergers and acquisitions. Moreover, partnerships and collaborations entered strategically lead to exploration of synergies for future growth.

Global Plant-based Biologics Market:  Key trends and driver

The global next generation memory market is being driven on to a high growth trajectory, owing to a number of factors. Some of the most potent ones are outlined below:

Global Biologics Manufacturers are shifting focus to plant biologics owing to limited availability of alternatives such as mammalian cultures. They not only have the expertise in the field but also core competencies. Besides, as chronic diseases see a rise in incidence, demands for these increase and to meet the unmet demand, plant based biologics offer the perfect alternative. In the United Sates, six in every ten people suffer from a chronic disease and four in evert ten suffer from at least two.

The reason for rising demand for biologics is that they offer a new treatment mechanism. This applies to a wide range of diseases and also includes cancer and immune disorders. Contributing massively is also the innovations and technological advancements, lowering manufacturing costs, allowing for easy storage of plant-based biologics.

Global Plant-based Biologics Market:  Regional Analysis

The North American region is set to dominate the market playfield owing to the presence of a wide number of government and private research institutions working actively in the field. An example here would be of Fraunhofer Centre for Molecular Biotechnology. In 2015, it finished off clinical trials for plant-derived recombinant protective antigen (Biological: PA83-FhCMB) for anthrax vaccine.

The report is segmented into the following:

On the basis of plant system, the global plant-based biologics market is segmented into:

  • Leaf-based 
  • Seeds-based 
  • Fruits-based 
  • Tubers-based 
  • Others

On the basis of source, the global plant-based biologics market is segmented into:

  • Carrot
  • Tobacco
  • Duckweed
  • Rice
  • Moss
  • Alfalfa
  • Others

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.